HARVARD BIOSCIENCE, INC. Pro Forma Weighted Average Shares Outstanding, Diluted
HARVARD BIOSCIENCE, INC. (HBIO) reported Pro Forma Weighted Average Shares Outstanding, Diluted of 4.44 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted · last filed 2026-03-13
- HARVARD BIOSCIENCE, INC. pro forma weighted average shares outstanding, diluted for fiscal 2025 was 4.44M shares.
| Period end | Pro Forma Weighted Average Shares Outstanding, Diluted 12 month |
|---|---|
| 2025-12-31 | 4.44M shares 10-K · filed 2026-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |